Chemfab Alkalis Ltd (CHEMFAB) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Chemfab Alkalis Ltd on NSE and BSE, with an AI summary of each filing.
Submission of Investor presentation for quarter ended September 30, 2026.
Investor Presentation · 29 Oct 2026, 4:14 am
Chemfab Alkalis Q2 FY27 Performance Update and Expansion Roadmap Chemfab Alkalis reported consolidated revenue from operations of ₹75.61 crore in Q2 FY27, down 1.24% YoY (+3.35% QoQ), with operational EBITDA declining 30.50% QoQ to ₹7.04 crore (9.31% margin) and a PBT loss of ₹2.95 crore. Chemical segment ECU realizations softened to ₹38,000/MT, while the OPVC segment posted revenue of ₹6.39 crore. Management anticipates stronger consolidated performance in H2 FY27 driven by stabilizing caustic prices, cost-efficiency projects, and expanding Sri City OPVC pipe capacity to 23,000 TPA by Q4 FY27 to capture government infrastructure demand.
Chemfab Alkalis Limited has informed the Exchange regarding changes In Designations In Composition Of The Stakeholders Relationship Committee
Intimation · 28 Oct 2026, 5:30 am
Submission of letter for Changes in designations in Stakeholder Relationship Committee
Others (Uncategorized) · 29 Oct 2026, 1:38 am
Chemfab Alkalis Appoints COO and Reconstitutes Stakeholders Committee Chemfab Alkalis approved its un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26 at its board meeting on 28th Oct'26. The board appointed V. R. Raguraman as Chief Operating Officer (Senior Management Personnel) with immediate effect, leveraging his four decades of chemical manufacturing experience. Additionally, the Stakeholders Relationship Committee was reconstituted, re-designating Satish Narain Jajoo as Chairperson and Mrs. Drushti Desai as Member, alongside Suresh Krishnamurthi Rao.
Chemfab Alkalis Limited has informed the Exchange regarding Outcome of Board Meeting held on October 28, 2026 wrt approval by board in designating Chief Operating Officer (Senior Management Personnel)
Intimation · 28 Oct 2026, 5:30 am
Chemfab Alkalis Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Intimation · 28 Oct 2026, 5:30 am
Submission of approval by the Board wrt. designating Chief Operating Officer (Senior Management Personnel) in the Company at its meeting held on 28th October 2026
Change in Management · 29 Oct 2026, 1:14 am
Chemfab Alkalis Appoints V. R. Raguraman as Chief Operating Officer Chemfab Alkalis Limited approved its un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26 on 28th Oct'26. The Board appointed Mr. V. R. Raguraman as Chief Operating Officer (Senior Management Personnel) with immediate effect, bringing over four decades of chemical manufacturing experience. Additionally, the Stakeholders Relationship Committee was reconstituted, appointing Mr. Satish Narain Jajoo as Chairperson and re-designating Mrs. Drushti Desai as a Member.
Submission of Unaudited financial results for quarter and half year ended 30th September 2026
Financial Result · 29 Oct 2026, 1:05 am
In the Board meeting held today i.e., 28th October, 2026, the Board has approved Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2026
Outcome · 29 Oct 2026, 12:49 am
Chemfab Alkalis Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 7,561 (-1.2% YoY | +3.4% QoQ) ■ EBITDA: 704 (+28.8% YoY | -30.5% QoQ) ■ EBITDA Margin (%): 9.3 (+217 bps YoY | -454 bps QoQ) ■ PAT: -211 (-4.8% YoY | Profit to Loss QoQ) ■ EPS (INR): -1.47 (-5.0% YoY | Profit to Loss QoQ) Chemfab Alkalis Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Chemicals and related Products ■ Revenue: 6,922 (+39.0% YoY | +2.7% QoQ) ■ EBIT: 232 (Loss to Profit YoY | -20.7% QoQ) ■ EBIT Margin (%): 3.3 (Loss to Profit YoY | -99 bps QoQ) PVC-O Pipes ■ Revenue: 639 (-76.3% YoY | +11.2% QoQ) ■ EBIT: -317 (Profit to Loss YoY | -454.8% QoQ) ■ EBIT Margin (%): -49.6 (Profit to Loss YoY | -3969 bps QoQ)
Chemfab Alkalis Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 28 Oct 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 28 Oct 2026, 5:30 am
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve The Un-Audited Standalone and ....
Intimation · 28 Oct 2026, 5:30 am
Chemfab Alkalis Schedules Board Meeting for Q2 FY27 Financial Results Chemfab Alkalis Limited has scheduled a meeting of its Board of Directors on 28th Oct'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company shares by designated persons and insiders remains closed from 1st Oct'26 until 30th Oct'26, reopening 48 hours after the declaration of the financial results.
Submission of Credit Rating Letter issued by India Ratings and Research (Ind-Ra) with respect to Company''s Bank loan facilities
Others (Uncategorized) · 08 Oct 2026, 8:33 pm
India Ratings Affirms Chemfab Alkalis at 'IND BBB+'/Negative on Sluggish OPVC Demand India Ratings has affirmed Chemfab Alkalis Limited’s bank loan facilities of INR 1,700 million at 'IND BBB+/Negative/IND A2'. The Negative outlook reflects subdued operating performance across FY26 and 1QFY27, driven by low demand for OPVC pipes under the Jal Jeevan Mission, which elevated net leverage to 4.0x in FY26. However, chlor-alkali profitability improved in 1QFY27 via modernised electrolyser efficiency and hybrid power cost savings of ~INR 150 million annually. Liquidity remains supported by INR 555 million in capex reimbursement borrowings and available credit lines.
We wish to inform you that copy of the voting results along with the report of scrutinizer for the Annual General Meeting of the company held on 09th September 2026
Annual General Meeting · 11 Sept 2026, 8:35 pm
Submission of initmation of appointment of Statutory Auditors at AGM of the Company.
Change in Auditor · 10 Sept 2026, 12:51 am
Submission of summary of AGM proceedings held on 9th September, 2026 at 10 AM
Annual General Meeting · 09 Sept 2026, 11:46 pm
Revised copy of AGM notice due to typo errors in the special business set out in the previously submitted AGM Notice.
Annual General Meeting · 19 Aug 2026, 12:18 am
Submission of Revised notice of AGM which forms part of Annual Report for FY 2025-26 due typographical error in the serial numbers of Special Business as set out in the notice of AGM.
Others (Uncategorized) · 18 Aug 2026, 11:51 pm
Submission of correspondence(s) sent to shareholders whose E-mail ID are not registered with Company/RTA/DP for accsessing the Annual Report of FY 2025-26
Annual Report · 18 Aug 2026, 8:18 pm
Submission of Intimation of Record date, for payment of dividend, as 02.09.2026
Dividend · 18 Aug 2026, 8:08 pm
Chemfab Alkalis Sets Record Date for FY26 Final Dividend Chemfab Alkalis has fixed Wed, 02nd Sep'26 as the record date to determine shareholder eligibility for the final dividend for the financial year 2025-26. The dividend proposal is subject to approval at the company's 17th Annual General Meeting (AGM), scheduled for Wed, 09th Sep'26. The dividend amount has not yet been specified.
Submission of Annual Report for FY 2025-26
Others (Uncategorized) · 18 Aug 2026, 12:57 am
Submission of notice of AGM scheduled to be held on 09th September 2026
Annual General Meeting · 18 Aug 2026, 12:48 am
Submission of Investor Presentation for the quarter ended 30th June 2026
Investor Presentation · 30 Jul 2026, 2:33 pm
Chemfab Alkalis Q1FY27: OPVC Weakness Weighs on Consolidated Performance In Q1FY27, consolidated revenue fell 20.1% YoY to ₹73.16 crore, with EBITDA down 10.4% to ₹10.13 crore. PBT declined 52.8% YoY to ₹2.22 crore. The OPVC segment was heavily impacted, with revenue plunging 85.1% YoY to ₹5.75 crore due to weak demand from the Jal Jeevan Mission. Conversely, the Chemical segment saw revenue grow 27.6% YoY to ₹67.41 crore, with EBITDA surging to ₹7.74 crore. ECU realisation improved sequentially to ₹39,600/MT, and a new 10MW captive power plant commenced operations in May'26.
Submission of approval by the Board of Directors, the appointment of Statutory Auditors, M/s. MSKA & Associates LLP (FRN 001595S/S000168) at its meeting held on 29th July 2026, subject ....
Change in Auditor · 30 Jul 2026, 1:54 am
Chemfab Alkalis Q1FY27 Results & New Auditor Appointment Chemfab Alkalis’ board approved on 29th Jul’26 the unaudited standalone results for the quarter ending 30th Jun’26. Net profit stood at ₹482.92 lakhs, down 10.5% YoY but up 210% QoQ. Revenue from operations was ₹7,302.14 lakhs, a 16.6% YoY decline but a 6.3% QoQ increase. The board also approved appointing MSKA & Associates LLP as Statutory Auditors for five years, replacing Deloitte Haskins & Sells LLP upon their term's expiry, subject to shareholder approval at the upcoming AGM.
Submission of unaudited financial results for the quarter ended 30th June, 2026
Financial Result · 30 Jul 2026, 1:28 am
Chemfab Alkalis Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 7,316 (-20.1% YoY | -2.2% QoQ) ■ EBITDA: 1,013 (-10.4% YoY | +18.9% QoQ) ■ EBITDA Margin (%): 13.8 (+150 bps YoY | +245 bps QoQ) ■ PAT: 573 (+124.9% YoY | +1082.5% QoQ) ■ EPS (INR): 3.99 (+125.4% YoY | +1073.5% QoQ) Chemfab Alkalis Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) Segmental Performance Chemicals and related Products ■ Revenue: 6,741 (+27.6% YoY | +9.3% QoQ) ■ EBIT: 292 (Loss to Profit YoY | +103.2% QoQ) ■ EBIT Margin (%): 4.3 (Loss to Profit YoY | +200 bps QoQ) PVC-O Pipes ■ Revenue: 575 (-85.1% YoY | -56.2% QoQ) ■ EBIT: -57.2 (Profit to Loss YoY | +34.3% QoQ) ■ EBIT Margin (%): -10.0 (Profit to Loss YoY | -331 bps QoQ)
In the Board meeting held today i.e., 29th July, 2026, the Board has approved Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 and Appointment ....
Outcome · 30 Jul 2026, 1:23 am